Comparison of the cost-effectiveness of upfront letrozole or anastrozole versus tamoxifen for early breast cancer in hormone receptor positive (HR+) postmenopausal women -the Cypriot perspective

Subjects

Subjects :

Oncology
Cancer Research
medicine.medical_specialty
Postmenopausal women
Cost effectiveness
business.industry
Letrozole
Perspective (graphical)
Anastrozole
Hormone receptor
Internal medicine
medicine
business
Tamoxifen
medicine.drug
Early breast cancer

Details

ISSN :

13596349

Volume :

6

Database :

OpenAIRE

Journal :

European Journal of Cancer Supplements

Accession number :

edsair.doi...........d3c71db48f45d1035c880512de5f140f

Full Text :

https://doi.org/10.1016/s1359-6349(08)70580-9